NIVF Stock Analysis: Buy, Sell, or Hold?
NIVF - NewGenIvf Group Limited Class A ordinary shares
$0.57
-0.07 (-10.60%)
▼
5d:
-39.96%
30d:
-55.78%
90d:
+9.17%
HOLD
MODERATE Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: Jun 30, 2026
21d
Get Alerted When NIVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NIVF shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NIVF shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.64
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$2.26
74.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NIVF is currently trading at $0.57, which is considered oversold relative to its 30-day fair value range of $0.75 to $1.37. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.1) compared to its historical average (0.2). Remarkably, the market is currently pricing in an annual earnings decline of 24.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NIVF is in a uptrend. The price is currently testing key support at $0.72. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.6% recently.
Market Sentiment: NIVF has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $900.00 (+140965.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NIVF is in a uptrend. The price is currently testing key support at $0.72. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.6% recently.
Market Sentiment: NIVF has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $900.00 (+140965.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.75 -
$1.37
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.6%)
- BULLISH: Trading 140965.8% below Wall St target ($900.00)
- CAUTION: 5-day price weakness (-40.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.75 -
$1.37
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.72
Resistance Level
$1.60
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.07
Wall Street Target
$900.00
(+140965.8%)
Revenue Growth (YoY)
11.9%
Profit Margin
209.0%
Valuation Discount vs History
-24.8% cheaper
PE vs Historical
0.1 vs 0.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-24.8%
(market-implied from PE analysis)
1-Year Target
$0.57
(-10%)
2-Year Target
$0.52
(-19%)
3-Year Target
$0.47
(-27%)
3-Yr Target (if PE normalizes)
(PE: 0→0)
$1.36
(+113%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 97.0%)
$690.66
(+108154%)
Base:
(SPY PE: 0.1, Growth: 97.0%)
$2.15
(+238%)
Bear:
(PE: 0.1, Growth: 97.0%)
$1.83
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 0.02 | Current EPS (TTM): $36.48
Bull Case
$0.46
(-27%)
Analyst growth -50.0%, PE expands to 0.0
Base Case
$0.42
(-34%)
Market implied -50.0%, PE stable at 0.0
Bear Case
$0.57
(-10%)
Severe decline -20.0%, PE contracts to 0.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.1 to 0.2
Stabilization Target:
$1.87
(+192.8%)
PE Expansion Potential:
+192.8%
Share & Embed Analysis
Last updated: June 08, 2026 11:45 AM ET
Data refreshes hourly during market hours. Next update: 12:45 PM
Data refreshes hourly during market hours. Next update: 12:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NIVF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$245 | 51 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$507 | 56 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 56 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 57 HOLD |
